Improving computer algorithms for drug discovery simulations
Algorithmic improvements in large scale polarizable QM/MM simulations
This study is working on making computer programs better at predicting how drugs interact with proteins and other substances, which can help researchers and drug companies create new medicines more quickly and accurately.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Q-Chem, INC. NIH-funded |
| Lab location | 1 site (Pleasanton, United States) |
| Project ID | NIH-10673145 on NIH RePORTER |
What this research studies
This research focuses on enhancing computational tools that model chemical reactions in complex environments, such as within proteins and solvents. By developing advanced algorithms and software, the project aims to make these simulations faster and more accurate, which is crucial for drug discovery. The team will implement new methods to reduce computational costs and improve the efficiency of simulations, allowing for better predictions of how drugs interact at a molecular level. This work is particularly relevant for both academic researchers and pharmaceutical companies involved in drug design.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals with conditions that require new drug development or improved therapeutic options.
Not a fit: Patients with conditions that are already well-managed by existing treatments may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug discovery processes, resulting in better medications for patients.
How similar studies have performed: Other research in computational drug design has shown significant success, indicating that this approach has the potential for impactful advancements.
Where this research is happening
Pleasanton, United States
- Q-Chem, INC. — Pleasanton, United States (Active)
Researchers
- Principal investigator: Feng, Xintian — Q-Chem, INC.
- Study coordinator: Feng, Xintian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.